Business Context and Reporting Period
This Form 8-K is filed by Mill City Ventures III, Ltd. (the "Company") on July 18, 2025. The report addresses a corporate governance event involving the unexpected passing of independent director Laurence S. Zipkin on July 9, 2025, and the subsequent notification from Nasdaq regarding listing rule non-compliance.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and listing status rather than financial performance.
Material Changes
- Board Composition: The death of Mr. Zipkin resulted in the loss of an independent director, causing the Board to fall below the required majority of independent directors under Nasdaq Listing Rule 5605(b)(1).
- Audit Committee: The vacancy also caused the Audit Committee to fall below the requirement of having at least three independent directors under Nasdaq Listing Rule 5605(c)(2).
- Listing Status: The Company received a letter from Nasdaq on July 18, 2025, indicating it no longer complies with these specific listing standards.
Outlook, Risks, and Management Commentary
Cure Period: The Company has until the earlier of its next annual shareholder meeting or July 9, 2026 (or January 5, 2026, if the meeting occurs before that date) to cure the deficiencies.
Management Plan: The Board intends to appoint a new independent director to fill the vacancy on the Board and the Audit Committee prior to the end of the cure period to restore compliance.
Risks: Failure to cure the deficiency within the specified timeframe could result in delisting from the Nasdaq stock market.
Key Facts for Investor Verification
- Verify the timeline for the appointment of a new independent director to ensure compliance with the July 9, 2026 deadline.
- Monitor future filings for the date of the next annual shareholder meeting, as this may alter the cure deadline to January 5, 2026.
- Confirm the qualifications of any newly appointed director to ensure they meet Nasdaq's definition of "independent."